Tularik Inc. Common Stock ($0.001 par value)Amgen Inc • November 13th, 2003 • Biological products, (no disgnostic substances)
August 29, 2003Personal and Confidential • November 13th, 2003 • Amgen Inc • Biological products, (no disgnostic substances)
AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 13th, 2003 • Amgen Inc • Biological products, (no disgnostic substances) • California
THIS AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT (the “Amendment”) is made effective as of November 10, 2003, by and between TULARIK INC., a Delaware corporation (the “Company”), and AMGEN INC., a Delaware corporation (“Amgen”).
AGREEMENT RELATED TO STOCK PURCHASEStock Purchase • November 13th, 2003 • Amgen Inc • Biological products, (no disgnostic substances) • California
THIS AGREEMENT RELATED TO STOCK PURCHASE (the “Agreement”) is made and entered into as of November 10, 2003 (the “Execution Date”) by and between TULARIK INC., a Delaware corporation having its principal place of business at 1120 Veterans Boulevard, South San Francisco, CA 94080 (the “Company”), and AMGEN INC., a Delaware corporation having its principal place of business at One Amgen Center Drive, Thousand Oaks, CA 91320-1799 (“Amgen”). The Company and Amgen are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
